openPR Logo
Press release

Hodgkin’s Lymphoma Treatment Market Industry Demand, Top Key Players Review | BRISTOL MYERS SQUIBB, F HOFFMANN-LA ROCHE, MERCK & CO., PFIZER, 4SC AG, ACTINIUM PHARMACEUTICALS, AETERNA ZENTARIS, AFFIMED THERAPEUTICS AG

09-20-2018 12:25 PM CET | Health & Medicine

Press release from: Market Prognosis

The global Hodgkin’s Lymphoma treatment market is expected to register a CAGR of around 15%. Developed countries, such as the United States, Germany, United Kingdom, and Japan are expected to register robust growth.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/16699
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Rising Incidence of Hodgkin’s Lymphoma
According to the American Cancer Society, estimates for Hodgkin’s disease in the United States for 2017 were about 8,260 new cases (3,610 women and 4,650 men), and about 1,070 deaths (440 women and 630 men) from this cancer. Such an increase in number of new cases diagnosed every year, has been driving the Hodgkin’s lymphoma treatment market. The Lymphoma Research Foundation is spreading awareness on lymphoma, and is also funding the research and development required to eradicate lymphoma.

Key Developments in the Market
October 2017 - FDA approved the second gene altering therapy Yescarta for the cancer. The therapy was approved for blood cancer and non-Hodgkin’s lymphoma.
September 2017 - Aliqopa was approved by FDA, for the treatment of lymphoma.

Major Players –
BRISTOL MYERS SQUIBB, F HOFFMANN-LA ROCHE, MERCK & CO. INC., PFIZER INC., 4SC AG, ACTINIUM PHARMACEUTICALS, AETERNA ZENTARIS INC., AFFIMED THERAPEUTICS AG, HOSPIRA INC., INCYTE CORP, NOVARTIS AG, amongst others.

Request Discount on this report @https://marketprognosis.com/discount-request/16699
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Adverse Long-term Side-effects of Treatment
The treatment of Hodgkin’s lymphoma is associated with physical side-effects. People who received treatment for Hodgkin’s lymphoma have an increased risk of developing other diseases and conditions later. The side-effects can also result from cancer therapy, as radiation therapy and chemotherapy can cause permanent damage in patients. For instance, radiation therapy to the pelvic area can cause infertility, unless the ovaries or testicles are shielded during treatment. Some people have a higher risk of developing secondary cancer, especially myeloid leukemia, lung cancer, or breast cancer. Radiation therapy to the neck area can cause problems in thyroid gland, most commonly, hypothyroidism. Chemotherapy can result in suppressed blood cell formation, leading to anemia. Chemotherapy drugs kill cancer cells, but they could result in damage of normal cells as well. Several chemotherapy drugs, particularly anthracyclines, can cause heart damage, which may increase the risk of heart failure, over time. In the developing countries, reimbursement is low, which may hinder the growth of the market.

North America to Dominate the Market
The Hodgkin’s Lymphoma treatment market has been segmented by treatment type and geography. By geography, it has been segmented into North America, Europe, Asia-Pacific, the Middle East & Africa, and South America.
Due to the presence of well-established healthcare facilities, North America dominates the Hodgkin’s Lymphoma treatment market. However, the Asia-Pacific segment is expected to register the highest CAGR over the forecast period, as government and private firms are making significant investments on the healthcare industry. Over the last couple of years, there have several mergers, acquisitions, and collaborations between companies, to invest in the Japanese market.

Enquiry Before Buying@ https://marketprognosis.com/enquiry/16699
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMarkPvt Ltd,
Thane - 421501
India.
Contact No:+1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hodgkin’s Lymphoma Treatment Market Industry Demand, Top Key Players Review | BRISTOL MYERS SQUIBB, F HOFFMANN-LA ROCHE, MERCK & CO., PFIZER, 4SC AG, ACTINIUM PHARMACEUTICALS, AETERNA ZENTARIS, AFFIMED THERAPEUTICS AG here

News-ID: 1251300 • Views:

More Releases from Market Prognosis

Third-Party Logistics (3PL) Market Latest Study Focuses On Current, Future Innovations and Foreseen Till 2026 | FedEx, Exel Logistics, Menlo Worldwide Logistics, Ryder Logistics
Third-Party Logistics (3PL) Market Latest Study Focuses On Current, Future Innov …
The report covers a forecast and an analysis of the Third-Party Logistics (3PL) Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume. Overview of the Global Third-Party Logistics (3PL) Market: The report spread across 90 pages is an overview of the Global Third-Party Logistics (3PL) Market. These report study based on the Third-Party
Ride-Hailing Market: An Insight on the Important Factors and Trends Influencing by Top Key Players (Didi, Uber, Lyft, Gett, Hailo, Ola Cabs, Cabify, GoCatch) | Foreseen Till 2026
Ride-Hailing Market: An Insight on the Important Factors and Trends Influencing …
The report covers a forecast and an analysis of the Ride-Hailing Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume. Overview of the Global Ride-Hailing Market: The report spread across 90 pages is an overview of the Global Ride-Hailing Market. These report study based on the Ride-Hailing Market. It is a complete overview
COVID-19 Impact on Professional Indemnity Insurance Market 2021-2026: Industry Insight and Growth Strategy by Business Players - AIG, Chubb (ACE), Allianz, XL Group, AXA, Aviva
COVID-19 Impact on Professional Indemnity Insurance Market 2021-2026: Industry I …
The report covers a forecast and an analysis of the Professional Indemnity Insurance Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume. Overview of the Global Professional Indemnity Insurance Market: The report spread across 90 pages is an overview of the Global Professional Indemnity Insurance Market. These report study based on the Professional
Modular Construction Market Future Growth Explored in Latest Research Report by 2026 | Komatsu, Kiewit, Skanska, L&T, Taisei, ACS Group, Bouygues Construction
Modular Construction Market Future Growth Explored in Latest Research Report by …
The report covers a forecast and an analysis of the Modular Construction Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume. Overview of the Global Modular Construction Market: The report spread across 90 pages is an overview of the Global Modular Construction Market. These report study based on the Modular Construction Market. It

All 5 Releases


More Releases for Hodgkin’s

Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market to Witness Major …
Market Analysis and Insights: Global Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Non-hodgkin’s lymphoma and chronic lymphoma treatment market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 673.59 million by 2027 growing with the CAGR of 7.25% in the above-mentioned forecast period. Growing cases of cancer and chronic diseases among population is driving the
Hodgkin’s Lymphoma Treatment Market Segmented by Technology, Component, Indust …
The Hodgkin’s Lymphoma Treatment market report presents the global Hodgkin’s Lymphoma Treatment sales and revenue by companies, regions, type and application and forecast to 2027. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis. Hodgkin’s Lymphoma Treatment Market competition landscape by sales volume, price (USD/Unit), revenue (Million USD), cost profit analysis
Hodgkin’s Lymphoma Treatment Market Major Players Emcure Pharmaceuticals Pvt. …
Lymphoma is a cancer caused in lymphocytes of the body, i.e. white blood cells. It is of two types – Hodgkin’s Lymphoma and Non-Hodgkin’s Lymphoma. Hodgkin’s Lymphoma can be characterized into two categories – classic and nodular lymphocyte predominant. Some of the signs indicating presence of Hodgkin’s Lymphoma in the body is fever, sudden weight loss, and swollen lymph nodes. Hodgkin’s Lymphoma is mostly treated with chemotherapy alone or with
Non-Hodgkin’s Lymphoma Disease Pipeline Drugs Assessment: Clinical Trails Anal …
Non-Hodgkin’s Lymphoma Disease Pipeline Drugs Assessment Overview: Non-Hodgkin’s lymphoma is a cancer which originates in lymphatic system. Non-Hodgkin’s lymphoma tumours develop from lymphocytes. It is more common than Hodgkin’s lymphoma. Several type of non-Hodgkin lymphomas, among them follicular lymphoma and diffuse B-Cell lymphoma are most common subtypes. Symptoms may include painless swelling of limp nodes in neck, armpits or groin, abdominal pain, chest pain and others. Disease will be diagnosed through
Non-Hodgkin’s Lymphoma Industry Size, Company Share And Distribution Share Dat …
"The Latest Research Report EpiCast Report: Non-Hodgkin’s Lymphoma - Epidemiology Forecast to 2024 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" EpiCast Report: Non-Hodgkins Lymphoma - Epidemiology Forecast to 2024 Summary Non-Hodgkins Lymphoma (NHL) refers to a group of cancers that develop in the lymphatic system. In NHL, the bodys immune system is affected by the uncontrollable growth of malignant white blood cells, resulting
Non-Hodgkin’s Lymphoma Research Report States Number of B-cell NHL cases will …
"The Report EpiCast Report: Non-Hodgkin’s Lymphoma - Epidemiology Forecast to 2024 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" MarketResearchReports.biz has added a new research report, titled “EpiCast Report: Non-Hodgkin’s Lymphoma - Epidemiology Forecast To 2024,” to its vast database. The research report on non-Hodgkin lymphoma or NHL explains the nature of the disease with a complete chapter on its